A detailed history of Fieldview Capital Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fieldview Capital Management, LLC holds 2,912 shares of GILD stock, worth $306,488. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,912
Holding current value
$306,488
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$83.95 - $97.9 $244,462 - $285,084
2,912 New
2,912 $269 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $132B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Fieldview Capital Management, LLC Portfolio

Follow Fieldview Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldview Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldview Capital Management, LLC with notifications on news.